Page 1 of Clinical Trials for ( Antibodies AND Neoplasm ), 2944 Total Matches
- 1Active, not recruitingLast Updated: May 18, 2012Condition(s): Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer
- 2Active, not recruitingLast Updated: April 23, 2011Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer
- 3TerminatedLast Updated: February 6, 2009Condition(s): Colorectal Cancer; Neoplasm Metastasis
- 4CompletedLast Updated: March 12, 2010Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Precancerous/Nonmalignant Condition; Unspecified Adult Solid Tumor, Protocol Specific
- 5CompletedLast Updated: June 9, 2009Condition(s): Prostate Cancer
- 6RecruitingLast Updated: May 9, 2011Condition(s): Colorectal Neoplasms; Colorectal Cancer; Colorectal Tumor; COlorectal Carcinoma
- 7CompletedLast Updated: April 18, 2009Condition(s): Head and Neck Cancer
- 8Active, not recruitingLast Updated: February 28, 2009Condition(s): Lung Cancer
- 9Active, not recruitingLast Updated: February 28, 2009Condition(s): Lung Cancer
- 10RecruitingLast Updated: April 16, 2012Condition(s): Lung Cancer
- 11WithdrawnLast Updated: April 7, 2011Condition(s): Metastatic Solid Tumors
- 12Active, not recruitingLast Updated: February 12, 2011Condition(s): Breast Cancer; Hypercalcemia of Malignancy; Metastatic Cancer; Pain
- 13RecruitingLast Updated: April 16, 2012Condition(s): Liver Metastases; Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer
- 14CompletedLast Updated: April 22, 2010Condition(s): Brain and Central Nervous System Tumors; Intraocular Melanoma; Lung Cancer; Melanoma (Skin); Neuroblastoma; Retinoblastoma; Sarcoma
- 15CompletedLast Updated: February 6, 2009Condition(s): Ovarian Cancer
- 16Active, not recruitingLast Updated: July 21, 2011Condition(s): Prostate Cancer
- 17CompletedLast Updated: February 6, 2009Condition(s): Breast Cancer
- 18CompletedLast Updated: February 6, 2009Condition(s): Ovarian Cancer
- 19Active, not recruitingLast Updated: March 9, 2012Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 20RecruitingLast Updated: February 28, 2012Condition(s): Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Refractory Anemia With Excess Blasts; Secondary Acute Myeloid Leukemia
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Antibodies%2C+Neoplasm
